Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 20 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Anastasilakis, A D  [Clear All Filters]
Journal Article
Anastasilakis, A. D., Polyzos S. A., Makras P., Gkiomisi A., Savvides M., Papatheodorou A., et al. (2013).  Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment.. Osteoporos Int. 24(7), 2127-32.
Anastasilakis, A. D., Polyzos S. A., Makras P., Gkiomisi A., Bisbinas I., Katsarou A., et al. (2014).  Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months.. Osteoporos Int. 25(5), 1633-42.
Anastasilakis, A. D., Polyzos S. A., Makras P., Savvides M., Sakellariou G. T., Gkiomisi A., et al. (2014).  Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment.. Horm Metab Res. 46(2), 145-9.
Anastasilakis, A. D., Polyzos S. A., Karathanasi E., & Efstathiadou Z. (2011).  Coincidence of severe primary hyperparathyroidism and primary hypothyroidism in a postmenopausal woman with low bone mass--initial conservative management.. J Musculoskelet Neuronal Interact. 11(1), 77-80.
Anastasilakis, A. D., Makras P., Doulgeraki A., Polyzos S. A., Guarnieri V., & Papapoulos S. E. (2021).  Denosumab for the treatment of primary pediatric osteoporosis.. Osteoporos Int.
Anastasilakis, A. D., Polyzos S. A., Gkiomisi A., Saridakis Z. G., Digkas D., Bisbinas I., et al. (2015).  Denosumab versus zoledronic acid in patients previously treated with zoledronic acid.. Osteoporos Int. 26(10), 2521-7.
Anastasilakis, A. D., Polyzos S. A., Avramidis A., Papatheodorou A., & Terpos E. (2009).  Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.. Horm Metab Res. 41(7), 559-62.
Polyzos, S. A., Anastasilakis A. D., Efstathiadou Z., Kita M., Litsas I., Avramidis A., et al. (2009).  The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone.. Horm Metab Res. 41(11), 846-50.
Anastasilakis, A. D., Toulis K. A., Goulis D. G., Polyzos S. A., Delaroudis S., Giomisi A., et al. (2009).  Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis.. Horm Metab Res. 41(10), 721-9.
Anastasilakis, A. D., Goulis D. G., Polyzos S. A., Gerou S., Koukoulis G. N., Efstathiadou Z., et al. (2008).  Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial.. Int J Clin Pract. 62(6), 919-24.
Voskaridou, E., Christoulas D., Plata E., Bratengeier C., Anastasilakis A. D., Komninaka V., et al. (2012).  High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.. Horm Metab Res. 44(12), 909-13.
Anastasilakis, A. D., Polyzos S. A., Delaroudis S., Toulis K. A., Mandanas S., Avgerinidou C., et al. (2012).  Long-term effects of thyroid fine-needle biopsy on the thyroid-related biochemical parameters.. Int J Clin Pract. 66(6), 602-9.
Polyzos, S. A., Anastasilakis A. D., Makras P., & Terpos E. (2011).  Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.. Exp Clin Endocrinol Diabetes. 119(9), 519-24.
Polyzos, S. A., & Anastasilakis A. D. (2011).  Rare potential complications of thyroid fine needle biopsy.. Hippokratia. 15(2), 116-9.
Anastasilakis, A. D., Toulis K. A., Nisianakis P., Goulis D. G., Kampas L., Valeri R-M., et al. (2012).  Selenomethionine treatment in patients with autoimmune thyroiditis: a prospective, quasi-randomised trial.. Int J Clin Pract. 66(4), 378-83.
Mpalaris, V., Anagnostis P., Anastasilakis A. D., Goulis D. G., Doumas A., & Iakovou I. (2016).  Serum leptin, adiponectin and ghrelin concentrations in post-menopausal women: Is there an association with bone mineral density?. Maturitas. 88, 32-6.
Anastasilakis, A. D., Goulis D. G., Polyzos S. A., Gerou S., Koukoulis G., Kita M., et al. (2008).  Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial.. Horm Metab Res. 40(4), 281-5.
Polyzos, S. A., Anastasilakis A. D., & Terpos E. (2013).  Serum sclerostin levels following treatment with parathyroid hormone.. J Endocrinol Invest. 36(4), 280.
Polyzos, S. A., Anastasilakis A. D., Bratengeier C., Woloszczuk W., Papatheodorou A., & Terpos E. (2012).  Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.. Osteoporos Int. 23(3), 1171-6.
Polyzos, S. A., Kountouras J., Anastasilakis A. D., Litsas I., Kita M., Arsos G., et al. (2011).  Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone.. Osteoporos Int. 22(1), 363-7.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές